Comerica CMA · NYSE
$90.47 +2.05% (+$1.82)
Summary
38 / 100 · Bulios Score
What speaks for it
- It bought back its own shares for $1.34B in the last fiscal year, 12% of its market value.
- It has been profitable 6 years in a row.
What to watch
- The share price is above the Bulios Fair Price.
- Revenue fell by 0.6% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 16.9 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
- Analyst estimate
Revenue grew by 5.6% a year over 5 years. Over the last 3 years it fell by 0.6% a year. Earnings per share grew by 2.3% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 3.20%
- Paid out of profit
- 51%
You receive $1.42 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Neutral- Buy 15
- Hold 35
- Sell 12
No analyst has published a price target.
24% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
This revenue breakdown is on the way.
By region
This revenue breakdown is on the way.